Analyst Alerts: New York Times, McDonald’s, Amarin, Halliburton June 7th

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

The New York Times Company (NYSE:NYT): Citigroup believes two potential catalysts could cause shares of New York Times (NYSE:NYT) to outperform shares of Gannett (NYSE:GCI) in the near-term. Citi sees a potential dividend and the naming of a new CEO as potential catalysts for New York Times, but keeps a Neutral rating on the stock.

McDonald’s Corp. (NYSE:MCD): McDonald’s added to short-term buy list at Deutsche Bank

Amarin Corporation plc (NASDAQ:AMRN): Leerink said its survey indicated physicians prefer the clinical profile of Amarin’s AMR101 and expect it to take share from GSK’s Lovaza while also expanding the prescription Omega-3 market significantly. Leerink thinks AMR101 can reach sales of $1.4B in three years and keeps an Outperform rating on the stock.

Halliburton Company (NYSE:HAL): RBC Capital reduced its target on Halliburton after the company lowered its Q2 operating margins. The firm expects increased guar gum costs, which drove the guidance change, to be transitory, and it maintains an Outperform rating on the stock. Goldman said Halliburton’s lowered NAM margin guidance is already reflected in valuation. The firm believes Q2 2012 will be the bottom in margins and that margins will significantly increase in 2013. The firm rates shares a Conviction Buy and also notes spot pressure pumping prices are stabilizing. Price target is $50.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business